Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 05, 2023 10:48 ET | Source: Research and Markets

Global Acute Myeloid Leukemia (AML) Therapeutics Strategic Research Report 2023: Market to Reach $1.6 Billion by 2030 with Cytarabine Accounting for $571.6 Million

Dublin, Dec. 05, 2023 (GLOBE NEWSWIRE) -- The "Acute Myeloid Leukemia (AML) Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Acute...
December 06, 2021 03:38 ET | Source: Research and Markets

Global Acute Myeloid Leukemia (AML) Therapeutics Market Report 2021: Market to Reach $976.2 Billion by 2026 - Emerging Drug Therapies/Targeted Therapies to Drive Future Growth

Dublin, Dec. 06, 2021 (GLOBE NEWSWIRE) -- The "Acute Myeloid Leukemia (AML) Therapeutics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering....
November 15, 2021 08:40 ET | Source: CMI

Antibody Drug Conjugates Market to Surpass US$ 11.01 Billion, Globally, by end of 2028, Says Coherent Market Insights (CMI)

SEATTLE, Nov. 15, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global antibody drug conjugates market is estimated to be valued at US$ 4.29 billion in 2021 and is expected to...
August 05, 2021 07:28 ET | Source: Research and Markets

Acute Myeloid Leukemia (AML) Market Insights & Epidemiology Analysis & Forecasts, 2018-2020 & 2021-2030: Major Markets, Marketed Therapies, Emerging Therapies, Case Reports, Patient Journey

Dublin, Aug. 05, 2021 (GLOBE NEWSWIRE) -- The "Acute Myeloid Leukemia (AML)- Market Insight, Epidemiology and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. The...
April 12, 2021 06:48 ET | Source: Research and Markets

Global Acute Myeloid Leukemia (AML) Disease Analysis Report 2021: On Average, it Takes 10.8 Years from Phase I to Approval, Compared to 9.6 Years in the Overall Oncology Space

Dublin, April 12, 2021 (GLOBE NEWSWIRE) -- The "Disease Analysis: Acute Myeloid Leukemia (AML)" report has been added to ResearchAndMarkets.com's offering. AML is a type of heterogeneous...
September 18, 2020 04:53 ET | Source: Research and Markets

Global Acute Myeloid Leukemia (AML) Disease Analysis Report 2020

Dublin, Sept. 18, 2020 (GLOBE NEWSWIRE) -- The "Disease Analysis: Acute Myeloid Leukemia (AML)" drug pipelines has been added to ResearchAndMarkets.com's offering. The publisher estimates that in...